Heidelberg, 30 November 2018 – Celiac disease is a severe autoimmune disorder of the intestine. It occurs when people develop sensitivity to gluten, a substance found in wheat, rye, and barley. An international research team from Italy and France has now uncovered a new molecular player in the development of gluten intolerance. Their discovery, published in The EMBO Journal, suggests potential targets for the development of therapeutic approaches for the disease. Read more.
Also have a read of this study relating to celiac disease and cystic fibrosis.
“As reported by Genkova (2013), the sweat test may be false positive in the presence of the malabsorption syndrome9 which may raise doubts as regards diagnosis between the two diseases. This emphasizes the importance of careful clinical observation in medical practice. The possibility of diagnostic confusion between these diseases may delay the adequate treatment of each disease.”
